Kurt Von Emster, Director at CRISPR Therapeutics AG (CRSP), bought 131,868 shares at $22.75 ($3.0M) on 2018-01-05, disclosed to the SEC on 2018-01-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.75 | 65,934 | $1.5M | 50.0% |
| 2 | $22.75 | 65,934 | $1.5M | 50.0% |
| Total | $22.75 avg | 131,868 | $3.0M | 100% |
| Filing → |
| VERA | BUY | 2021-05-18 | $8.9M | — | Filing → |
| PCVX | BUY | 2020-06-18 | $200K | — | Filing → |
| CRSP | SELL | 2019-01-18 | $3.7M | — | Filing → |